Antiischemic properties of fasudil in experimental models of vasospastic angina

Citation
S. Satoh et al., Antiischemic properties of fasudil in experimental models of vasospastic angina, JPN J PHARM, 87(1), 2001, pp. 34-40
Citations number
24
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JAPANESE JOURNAL OF PHARMACOLOGY
ISSN journal
00215198 → ACNP
Volume
87
Issue
1
Year of publication
2001
Pages
34 - 40
Database
ISI
SICI code
0021-5198(200109)87:1<34:APOFIE>2.0.ZU;2-#
Abstract
We studied the antiisehemic properties of fasudil, a Rho-kinase inhibitor, in conscious rabbits with coronary vasospasm induced by vasopressin and end othelin. Pretreatment with fasudil (0.3 and 3 mg/kg) attenuated the maximum elevation of the T-wave elicited by endothelin. Pretreatment with fasudil inhibited the T-wave elevation elicited by vasopressin. Fasudil and hydroxy fasudil, an active metabolite of fasudil. relaxed the endothelin, U-46619- 5-hydroxytryptamine- or histamine-induced contraction in swine coronary ar terial strips. Fasudil and hydroxy fasudil significantly prevented the redu ction in coronary flow by vasopressin in the Langendorff perfused rat heart . Fasudil was effective in protecting the heart against vasopressin and end othelin-induced myocardial ischemic change in conscious rabbits, and this b eneficial effect can be attributed to its action of ameliorating the severe contraction of arteries. The inhibition of Rho-kinase may have implication s for the development of novel therapeutic strategies for vasospastic angin a in patients.